Singapore markets closed

Straits Times Index
3,292.93
-3.96(-0.12%)
Nikkei
38,236.07
-37.98(-0.10%)
Hang Seng
18,475.92
+268.79(+1.48%)
FTSE 100
8,213.49
+41.34(+0.51%)
Bitcoin USD
63,202.75
+3,686.34(+6.19%)
CMC Crypto 200
1,359.39
+82.41(+6.45%)

LYEL May 2024 2.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.7500

0.0000

(0.00%)

At close: 11:23AM EDT

Simply Wall St.
Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns
Key Insights Institutions' substantial holdings in Lyell Immunopharma implies that they have significant influence over...
Zacks
Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know
Does Lyell Immunopharma (LYEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
GlobeNewswire
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, announced that three abstracts of new nonclinical data have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024 taking place in San Diego, CA, April 5-10. One oral and two poster presentations will highlight data fro